Valproic	valproic	CHEMICALS	O	OTHERS	I
acid	acid	CHEMICALS	O	OTHERS	I
I	i	O	O	O	O
:	:	O	O	O	O
time	time	O	O	O	O
course	course	O	O	O	O
of	of	O	O	O	O
lipid	lipid	O	O	O	O
peroxidation	peroxidation	O	O	O	O
biomarkers	biomarkers	O	O	O	O
,	,	O	O	O	O
liver	liver	O	O	OTHERS	I
toxicity	toxicity	O	DISEASE	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
valproic	valproic	CHEMICALS	O	OTHERS	I
acid	acid	CHEMICALS	O	OTHERS	I
metabolite	metabolite	O	O	O	O
levels	levels	O	O	O	O
in	in	O	O	O	O
rats	rats	O	O	O	O
.	.	O	O	O	O

A	a	O	O	O	O
single	single	O	O	O	O
dose	dose	O	O	O	O
of	of	O	O	O	O
valproic	valproic	CHEMICALS	O	OTHERS	I
acid	acid	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
VPA	vpa	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
,	,	O	O	O	O
which	which	O	O	O	O
is	is	O	O	O	O
a	a	O	O	O	O
widely	widely	O	O	O	O
used	used	O	O	O	O
antiepileptic	antiepileptic	O	O	O	O
drug	drug	O	O	O	O
,	,	O	O	O	O
is	is	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
oxidative	oxidative	O	O	O	O
stress	stress	O	O	O	O
in	in	O	O	O	O
rats	rats	O	O	O	O
,	,	O	O	O	O
as	as	O	O	O	O
recently	recently	O	O	O	O
demonstrated	demonstrated	O	O	O	O
by	by	O	O	O	O
elevated	elevated	O	O	O	O
levels	levels	O	O	O	O
of	of	O	O	O	O
15-F(2t)-isoprostane	15-f(2t)-isoprostane	O	O	OTHERS	I
(	(	O	O	O	O
15-F(2t)-IsoP	15-f(2t)-isop	O	O	OTHERS	I
)	)	O	O	O	O
.	.	O	O	O	O

To	to	O	O	O	O
determine	determine	O	O	O	O
whether	whether	O	O	O	O
there	there	O	O	O	O
was	was	O	O	O	O
a	a	O	O	O	O
temporal	temporal	O	O	O	O
relationship	relationship	O	O	O	O
between	between	O	O	O	O
VPA-associated	vpa-associated	O	O	O	O
oxidative	oxidative	O	O	O	O
stress	stress	O	O	O	O
and	and	O	O	O	O
hepatotoxicity	hepatotoxicity	O	DISEASE	OTHERS	I
,	,	O	O	O	O
adult	adult	O	O	O	O
male	male	O	O	O	O
Sprague-Dawley	sprague-dawley	O	O	O	O
rats	rats	O	O	O	O
were	were	O	O	O	O
treated	treated	O	O	O	O
ip	ip	O	O	O	O
with	with	O	O	O	O
VPA	vpa	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
500	500	O	O	O	O
mg/kg	mg/kg	O	O	O	O
)	)	O	O	O	O
or	or	O	O	O	O
0.9	0.9	O	O	O	O
%	%	O	O	O	O
saline	saline	O	O	O	O
(	(	O	O	O	O
vehicle	vehicle	O	O	O	O
)	)	O	O	O	O
once	once	O	O	O	O
daily	daily	O	O	O	O
for	for	O	O	O	O
2	2	O	O	O	O
,	,	O	O	O	O
4	4	O	O	O	O
,	,	O	O	O	O
7	7	O	O	O	O
,	,	O	O	O	O
10	10	O	O	O	O
,	,	O	O	O	O
or	or	O	O	O	O
14	14	O	O	O	O
days	days	O	O	O	O
.	.	O	O	O	O

Oxidative	oxidative	O	O	O	O
stress	stress	O	O	O	O
was	was	O	O	O	O
assessed	assessed	O	O	O	O
by	by	O	O	O	O
determining	determining	O	O	O	O
plasma	plasma	O	O	O	O
and	and	O	O	O	O
liver	liver	O	O	O	O
levels	levels	O	O	O	O
of	of	O	O	O	O
15-F(2t)-IsoP	15-f(2t)-isop	O	O	OTHERS	I
,	,	O	O	O	O
lipid	lipid	O	O	OTHERS	I
hydroperoxides	hydroperoxides	O	O	OTHERS	I
(	(	O	O	O	O
LPO	lpo	O	O	OTHERS	I
)	)	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
thiobarbituric	thiobarbituric	CHEMICALS	O	OTHERS	I
acid	acid	CHEMICALS	O	OTHERS	I
reactive	reactive	CHEMICALS	O	OTHERS	I
substances	substances	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
TBARs	tbars	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
.	.	O	O	O	O

Plasma	plasma	O	O	O	O
and	and	O	O	O	O
liver	liver	O	O	O	O
15-F(2t)-IsoP	15-f(2t)-isop	O	O	OTHERS	I
were	were	O	O	O	O
elevated	elevated	O	O	O	O
and	and	O	O	O	O
reached	reached	O	O	O	O
a	a	O	O	O	O
plateau	plateau	O	O	O	O
after	after	O	O	O	O
day	day	O	O	O	O
2	2	O	O	O	O
of	of	O	O	O	O
VPA	vpa	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
compared	compared	O	O	O	O
to	to	O	O	O	O
control	control	O	O	O	O
.	.	O	O	O	O

Liver	liver	O	O	O	O
LPO	lpo	O	O	OTHERS	I
levels	levels	O	O	O	O
were	were	O	O	O	O
not	not	O	O	O	O
elevated	elevated	O	O	O	O
until	until	O	O	O	O
day	day	O	O	O	O
7	7	O	O	O	O
of	of	O	O	O	O
treatment	treatment	O	O	O	O
(	(	O	O	O	O
1.8-fold	1.8-fold	O	O	O	O
versus	versus	O	O	O	O
control	control	O	O	O	O
,	,	O	O	O	O
p	p	O	O	OTHERS	I
<	<	O	O	O	O
0.05	0.05	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Liver	liver	O	O	O	O
and	and	O	O	O	O
plasma	plasma	O	O	O	O
TBARs	tbars	CHEMICALS	O	OTHERS	I
were	were	O	O	O	O
not	not	O	O	O	O
increased	increased	O	O	O	O
until	until	O	O	O	O
14	14	O	O	O	O
days	days	O	O	O	O
(	(	O	O	O	O
2-fold	2-fold	O	O	O	O
vs.	vs.	O	O	O	O
control	control	O	O	O	O
,	,	O	O	O	O
p	p	O	O	OTHERS	I
<	<	O	O	O	O
0.05	0.05	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Liver	liver	O	O	OTHERS	I
toxicity	toxicity	O	DISEASE	OTHERS	I
was	was	O	O	O	O
evaluated	evaluated	O	O	O	O
based	based	O	O	O	O
on	on	O	O	O	O
serum	serum	O	O	O	O
levels	levels	O	O	O	O
of	of	O	O	O	O
alpha-glutathione	alpha-glutathione	O	O	O	O
S-transferase	s-transferase	O	O	O	O
(	(	O	O	O	O
alpha-GST	alpha-gst	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
by	by	O	O	O	O
histology	histology	O	O	O	O
.	.	O	O	O	O

Serum	serum	O	O	O	O
alpha-GST	alpha-gst	O	O	O	O
levels	levels	O	O	O	O
were	were	O	O	O	O
significantly	significantly	O	O	O	O
elevated	elevated	O	O	O	O
by	by	O	O	O	O
day	day	O	O	O	O
4	4	O	O	O	O
,	,	O	O	O	O
which	which	O	O	O	O
corresponded	corresponded	O	O	O	O
to	to	O	O	O	O
hepatotoxicity	hepatotoxicity	O	DISEASE	OTHERS	I
as	as	O	O	O	O
shown	shown	O	O	O	O
by	by	O	O	O	O
the	the	O	O	O	O
increasing	increasing	O	O	O	O
incidence	incidence	O	O	O	O
of	of	O	O	O	O
inflammation	inflammation	O	DISEASE	OTHERS	I
of	of	O	O	O	O
the	the	O	O	O	O
liver	liver	O	O	O	O
capsule	capsule	O	O	O	O
,	,	O	O	O	O
necrosis	necrosis	O	DISEASE	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
steatosis	steatosis	O	O	OTHERS	I
throughout	throughout	O	O	O	O
the	the	O	O	O	O
study	study	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
liver	liver	O	O	O	O
levels	levels	O	O	O	O
of	of	O	O	O	O
beta-oxidation	beta-oxidation	O	O	O	O
metabolites	metabolites	O	O	O	O
of	of	O	O	O	O
VPA	vpa	CHEMICALS	O	OTHERS	I
were	were	O	O	O	O
decreased	decreased	O	O	O	O
by	by	O	O	O	O
day	day	O	O	O	O
14	14	O	O	O	O
,	,	O	O	O	O
while	while	O	O	O	O
the	the	O	O	O	O
levels	levels	O	O	O	O
of	of	O	O	O	O
4-ene-VPA	4-ene-vpa	O	O	O	O
and	and	O	O	O	O
(E)-2,4-diene-VPA	(e)-2,4-diene-vpa	O	O	O	O
were	were	O	O	O	O
not	not	O	O	O	O
elevated	elevated	O	O	O	O
throughout	throughout	O	O	O	O
the	the	O	O	O	O
study	study	O	O	O	O
.	.	O	O	O	O

Overall	overall	O	O	O	O
,	,	O	O	O	O
these	these	O	O	O	O
findings	findings	O	O	O	O
indicate	indicate	O	O	O	O
that	that	O	O	O	O
VPA	vpa	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
results	results	O	O	O	O
in	in	O	O	O	O
oxidative	oxidative	O	O	O	O
stress	stress	O	O	O	O
,	,	O	O	O	O
as	as	O	O	O	O
measured	measured	O	O	O	O
by	by	O	O	O	O
levels	levels	O	O	O	O
of	of	O	O	O	O
15-F(2t)-IsoP	15-f(2t)-isop	O	O	OTHERS	I
,	,	O	O	O	O
which	which	O	O	O	O
precedes	precedes	O	O	O	O
the	the	O	O	O	O
onset	onset	O	O	O	O
of	of	O	O	O	O
necrosis	necrosis	O	DISEASE	OTHERS	I
,	,	O	O	O	O
steatosis	steatosis	O	O	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
elevated	elevated	O	O	O	O
levels	levels	O	O	O	O
of	of	O	O	O	O
serum	serum	O	O	O	O
alpha-GST	alpha-gst	O	O	O	O
.	.	O	O	O	O

